MTA2 and gastric cancer: In contrast to its EMT-promoting role in CRC and HCC, SNHG5 has been reported to suppress EMT in gastric cancer by binding and retaining MTA2 in the cytoplasm, thereby inhibiting NuRD complex–mediated chromatin remodeling [33].